ドラッグデリバリーの市場規模、シェア、成長分析：タイプ別、技術別、用途別、使用施設別、地域別 - 産業予測 2025～2032年

ドラッグデリバリー市場規模は2023年に200億2,000万米ドルと評価され、2024年の217億米ドルから2032年には413億8,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは8.4%で成長する見通しです。

世界のドラッグデリバリー市場は、効果的で的を絞った医薬品投与の需要に牽引されて進化しています。慢性疾患では継続的な投薬が必要となることが多いため、ドラッグデリバリーの精度が最も重要です。植え込み型デバイス、注射器、吸入器を含む様々なシステムが、投与精度と患者のアドヒアランスを高めています。非侵襲的で低侵襲な代替薬へのシフトが顕著であり、経皮パッチ、経口デリバリーソリューション、点鼻薬などのイノベーションにつながっています。さらに、技術の進歩と個別化医療の重視の高まりが市場の成長を後押ししています。デジタルヘルス技術やスマートデリバリーシステムの導入は、リアルタイムのモニタリング、投与量の調整、オーダーメイドの治療計画を可能にし、この分野での新たなビジネスチャンスを生み出しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• エコシステムマッピング
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術評価
• 規制情勢
• 顧客と購買基準の分析
• パイプライン分析
• 疾病疫学
• スタートアップ分析
• 特許分析

ドラッグデリバリー市場規模：タイプ別

• 市場概要
• 吸入ドラッグデリバリー
• 注入ドラッグデリバリー
  • 従来の注射装置
  • 自己注射器
• 経口ドラッグデリバリー
  • 固形経口薬
  • 液体経口薬
  • 半固形経口薬
• 局所ドラッグデリバリー
  • 半固形外用剤
  • 液体外用剤
  • 固形局所用
  • 経皮局所
• 経肺ドラッグデリバリー
  • 定量吸入器
  • ドライパウダー吸入器
  • ネブライザー
• 経鼻ドラッグデリバリー
  • 鼻スプレー
  • 点鼻薬
  • 鼻用ジェル
  • 点鼻薬
• 経粘膜ドラッグデリバリー
  • 経口経粘膜製剤
  • 頬側ドラッグデリバリー
  • その他
• 埋め込み型ドラッグデリバリー
  • 受動型インプラントドラッグデリバリー
  • アクティブインプラントドラッグデリバリー
• 経皮ドラッグデリバリー
• その他

ドラッグデリバリー市場規模：技術別

• 市場概要
• 無針注射器
• ドラッグデリバリーパッチ
• 自動注射器
• その他

ドラッグデリバリー市場規模：用途別

• 市場概要
• がん
• 感染症
• 腫瘍学
• 糖尿病
• 心血管疾患
• 呼吸器疾患
• 中枢神経系疾患
• 中枢神経系疾患
• 自己免疫疾患
• その他

ドラッグデリバリー市場規模：使用施設別

• 市場概要
• 病院
• 外来手術センター
• ホームケア設定
• 診断センター
• その他

ドラッグデリバリー市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Johnson & Johnson
• Pfizer Inc.
• Novartis International AG
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Sanofi
• AstraZeneca plc
• Roche Holding AG
• Eli Lilly and Company
• Bayer AG
• Bristol-Myers Squibb Company
• AbbVie Inc.
• Amgen Inc.
• Novo Nordisk A/S
• Gilead Sciences, Inc.
• Takeda Pharmaceutical Company Limited
• Biogen Inc.
• Astellas Pharma Inc.
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Company, Limited

結論と推奨事項

Drug Delivery Market size was valued at USD 20.02 Billion in 2023 and is poised to grow from USD 21.7 Billion in 2024 to USD 41.38 Billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global drug delivery market is evolving, driven by the demand for effective, targeted pharmaceutical administration. As chronic diseases often require ongoing medication, precision in drug delivery is paramount. Various systems, including implantable devices, injectables, and inhalers, enhance dosing accuracy and patient adherence. There is a noticeable shift towards non-invasive and minimally invasive alternatives, leading to innovations like transdermal patches, oral delivery solutions, and nasal sprays. Additionally, technological advancements and the increasing emphasis on personalized medicine are propelling market growth. The incorporation of digital health technologies and smart delivery systems is further enhancing the landscape, enabling real-time monitoring, dose adjustments, and tailored treatment plans, thus creating new opportunities within the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Drug Delivery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Drug Delivery Market Segmental Analysis

Global Drug Delivery Market is segmented by type, technique, application, facility of use and region. Based on type, the market is segmented into inhalation drug delivery, injectable drug delivery, oral drug delivery, topical drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, implantable drug delivery, transdermal drug delivery and others. Based on technique, the market is segmented into needle-free injectors, drug delivery patches, autoinjectors and others. Based on application, the market is segmented into cancer, infectious diseases, oncology, diabetes, cardiovascular diseases, respiratory diseases, central nervous system disorders, CNS disorders, autoimmune diseases and others. Based on facility of use, the market is segmented into hospitals, ambulatory surgery centers, home care settings, diagnostic centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Drug Delivery Market

The global drug delivery market is experiencing significant growth driven by the rising demand for self-administration and home healthcare solutions. Patients are increasingly prioritizing convenience and autonomy in managing their treatment regimens. As a result, the market has seen the emergence of user-friendly and portable drug delivery devices, including autoinjectors, inhalers, and insulin pens, designed to facilitate at-home medication administration. These innovative devices not only empower patients by enabling them to self-manage their therapies but also minimize the frequency of hospital visits, thereby enhancing overall patient satisfaction and comfort in their healthcare journeys.

Restraints in the Drug Delivery Market

The drug delivery market faces notable restraints primarily due to the high costs associated with the development and manufacturing of sophisticated delivery systems. The expenses are amplified by comprehensive research and development initiatives, thorough clinical trials, intricate manufacturing protocols, and strict quality control requirements. Such financial burdens can hinder the broader implementation of these advanced technologies, especially in resource-constrained healthcare environments. Consequently, issues of affordability and cost-effectiveness emerge as critical factors that influence the accessibility and utilization of cutting-edge drug delivery solutions, thereby impacting their integration into mainstream medical practice.

Market Trends of the Drug Delivery Market

The Drug Delivery market is witnessing a significant trend towards targeted drug delivery systems, which focus on administering medications directly to specific sites within the body. This precision not only heightens treatment efficacy but also minimizes systemic side effects, making it increasingly favorable for managing complex diseases like cancer, autoimmune disorders, and chronic conditions. Innovations such as nanoparticles, liposomes, micelles, and implantable devices are at the forefront of this shift, enhancing drug efficacy and reducing dosage requirements. Additionally, targeted systems improve patient compliance and mitigate off-target effects, positioning them as a crucial component in the future of therapeutic strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree Of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2024
• Pestel Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology
• Startup Analysis
• Patent Analysis

Global Drug Delivery Market Size by Type & CAGR (2025-2032)

• Market Overview
• Inhalation Drug Delivery
• Injectable Drug Delivery
  • Conventional Injection Devices
  • Self-Injection Devices
• Oral Drug Delivery
  • Solid Oral Drugs
  • Liquid Oral Drugs
  • Semi Solid Oral Drugs
• Topical Drug Delivery
  • Semi Solid Topical
  • Liquid Topical
  • Solid Topical
  • Transdermal Topical
• Pulmonary Drug Delivery
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Nebulizers
• Nasal Drug Delivery
  • Nasal Sprays
  • Nasal Drops
  • Nasal Gels
  • Nasal Powders
• Transmucosal Drug Delivery
  • Oral Transmucosal Formulations
  • Buccal Drug Delivery
  • Others
• Implantable Drug Delivery
  • Passive Implantable Drug Delivery
  • Active Implantable Drug Delivery
• Transdermal Drug Delivery
• Others

Global Drug Delivery Market Size by Technique & CAGR (2025-2032)

• Market Overview
• Needle-Free Injectors
• Drug Delivery Patches
• Autoinjectors
• Others

Global Drug Delivery Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cancer
• Infectious Diseases
• Oncology
• Diabetes
• Cardiovascular Diseases
• Respiratory Diseases
• Central Nervous System Disorders
• CNS Disorders
• Autoimmune Diseases
• Others

Global Drug Delivery Market Size by Facility of Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Diagnostic Centers
• Others

Global Drug Delivery Market Size & CAGR (2025-2032)

• North America (Type, Technique, Application, Facility of Use)
  • USA
  • Canada
• Europe (Type, Technique, Application, Facility of Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technique, Application, Facility of Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technique, Application, Facility of Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technique, Application, Facility of Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo Company, Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations